Company: APXIF
Filing Date: 2025-03-31
Form Type: F-4/A
Source: 0001213900-25-026339
Chunk: 372

Company: APx Acquisition Corp. I
Filing Date: 2025-03-31
Form: F-4/A
Chunk 372
---
rigeneticists are certified and possess the necessary permissions and are authorized to operate within the telemedicine industry in Argentina. These professionals are qualified to provide telemedicine consultations in compliance with local regulations, and they maintain industry standards for telehealth practices to ensure safe and effective patient care. As we currently offer Rewell only in Argentina and Heritas Diagnostics in both Argentina and Paraguay, our operations are fully compliant with the local regulations applicable in each market. To maintain compliance in countries with strict telemedicine regulations, our telemedicine consultations will occur within the country of service, ensuring that providers are authorized under local laws to serve patients. Additionally, Rewell’s nutrigenetic consultations will be delivered by specialists familiar with local diets and health practices to offer culturally and geographically relevant recommendations. For Rewell’s expansion, this requires engaging nutrigeneticists from each specific country to tailor health guidance effectively to each customer’s unique needs within their geographic context. These nutrigeneticists will assist in the development of AI Agents catered to each specific geography. Regarding the integration of AI Agents into our telemedicine services, it is important to note that AI -specificregulations in these countries are still evolving. In Argentina, legislative proposals were introduced in 2023 aiming to regulate AI technologies, focusing on ethical and responsible use, with an emphasis on protecting human rights and privacy. As of now, these initiatives have not been enacted into law. Similarly, Mexico and Paraguay have yet to implement comprehensive AI policies, though discussions are ongoing. In the absence of specific AI regulations, our approach is to comply with existing healthcare and data protection laws in each country. We ensure that all AI -drivenservices are supervised by certified medical professionals authorized to operate within the telemedicine industry in their respective countries. This includes maintaining high standards of patient confidentiality, data security, and informed consent. We are committed to monitoring regulatory developments related to AI and telemedicine in all operating countries and will adapt our practices to ensure ongoing compliance with any new laws or guidelines. 191 Biological Sample Logistics and Data Transfer The collection, transport, and analysis of biological samples, as well as the cross -bordertransfer of biological data, must comply with each country’s regulations to protect patient safety and ensure data privacy. In Argentina, biological sample transport adheres to national and international safety standards, and data transfer is governed by the Personal Data Protection Law to ensure confidentiality. In Mexico, the General Health Law governs biological sample handling, while the Federal Law on the Protection of Personal Data governs